ASX:OCCPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Orthocell Ltd
$0.725
Day Range
$0.725 – $0.725
52 Week Range
$0.700 – $1.600
Volume
0.00
Avg Volume (10D)
268.68K
Price Chart
OHLC · volume · moving averages
$0.725-$0.175 (-19.44%)over 6M
Hi$1.110Lo$0.700Avg Vol347.7K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.725
Previous Close
$0.725
Day High
$0.725
Day Low
$0.725
52 Week High
$1.600
52 Week Low
$0.700
Valuation
Fundamental multiples
Market Cap
0.00
Shares Outstanding
0.00
Price to Book
4.88
Trading Activity
Volume & order book
Volume
0.00
Value Traded
0.00
Bid
$0.735 × 6,802
Ask
$0.735 × 8,311
Performance
Returns across timeframes
1 Day
-3.27%
5 Day
-4.52%
13 Week
-1.33%
52 Week
-36.21%
YTD
-31.80%
Technical Indicators
Momentum & moving averages
RSI (14)
41.38
50-Day SMA
$0.760
200-Day SMA
$0.864
— From the desk
Latest News
Biotechnology
Orthocell Appoints MediTime as Thai Distributor for Remplir Nerve Repair
Orthocell names MediTime exclusive Thai distributor for Remplir nerve repair, taps US$84m market; Thai FDA CY25 approval; $48m cash, no debt.
Biotechnology
Orthocell Secures Access to 221 US Military & VA Medical Centres for Remplir
Orthocell wins access to 221 US DoD/VA centres for Remplir, a major US market expansion as HY26 revenue hits A$6.2m and cash sits at A$49.4m.
Biotechnology
Orthocell's Remplir Device Used in 23 Ukrainian Soldier Surgeries, Validating Field Utility
Orthocell's Remplir validated after 23 Ukrainian surgeries, boosting defence-market traction and global expansion; HY26 revenue +49%, cash ~A$49m.
Biotechnology
Orthocell Appoints Exclusive Remplir Distributor Ahead of UK Rollout
Orthocell names LEDA Orthopaedics exclusive UK distributor for Remplir ahead of regulatory approval, signaling rapid UK rollout and market prep.